1. From the Université de Strasbourg, INSERM, EFS Grand-Est, BPPS UMR-S1255, FMTS, F-67065 Strasbourg, France (M.U.A., N.R., M.L.B., E.J.-B., F.L., C.G., P.H.M.)
2. Faculty of Physics, Moscow State University, Russia (V.K., D.N., M.P.)
3. Federal Research and Clinical Centre of Pediatric Hematology, Oncology and Immunology, Russia (V.K., D.N., M.P.)
4. Center for Theoretical Problems of Physicochemical Pharmacology, Russia (V.K., D.M., M.P.)
5. Université de Paris, INSERM, Hôpital Bichat, UMR-S1148, France (S.L., M.J.-P.)
6. CHU Lille, Université de Lille, INSERM UMR-SU1011–EGID, Institut Pasteur de Lille, France (M.D., A.R., S.S.)
7. Université de Strasbourg, Department of Vascular Surgery and Kidney Transplantation, France (N.C.)
8. The Australian National University, The John Curtin School of Medical Research, ACRF Department of Cancer Biology and Therapeutics, Canberra, Australia (E.E.G.)
9. Australian Centre for Blood Diseases, Monash University, Australia (R.K.A.)
10. Acticor Biotech, France (M.J.-P.).